Is H5N1 the next big threat? Discover how Alveo’s new diagnostic could be a game changer
Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics, has announced a significant advancement in its avian influenza diagnostic capabilities. The company has demonstrated through in silico analysis that its rapid, handheld point-of-need molecular diagnostic can accurately detect the H5N1 avian influenza variant, utilizing genetic sequences from recent infections in Colorado. On July […]